{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:08:14Z","timestamp":1792789694895,"version":"4.5.0"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2022M3E5E8081191"],"award-info":[{"award-number":["NRF-2022M3E5E8081191"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2022R1I1A1A01069717"],"award-info":[{"award-number":["NRF-2022R1I1A1A01069717"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020R1A2C1008084"],"award-info":[{"award-number":["2020R1A2C1008084"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.lfs.2024.122954","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T21:27:16Z","timestamp":1723238836000},"page":"122954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Current insights and therapeutic strategies for targeting TRPV1 in neuropathic pain management"],"prefix":"10.1016","volume":"355","author":[{"given":"Md. Mahbubur","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youn-Yi","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Kyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2024.122954_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"24","key":"10.1016\/j.lfs.2024.122954_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415854","article-title":"Diosgenin exerts analgesic effects by antagonizing the selective inhibition of transient receptor potential vanilloid 1 in a mouse model of neuropathic pain","volume":"23","author":"Rahman","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.lfs.2024.122954_bb0015","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3904\/kjim.2018.162","article-title":"Neuropathic cancer pain: prevalence, pathophysiology, and management","volume":"33","author":"Yoon","year":"2018","journal-title":"Korean J. Intern. Med."},{"issue":"1","key":"10.1016\/j.lfs.2024.122954_bb0020","article-title":"Autoimmune regulation of chronic pain","volume":"6","author":"Lacagnina","year":"2021","journal-title":"Pain Rep"},{"issue":"7","key":"10.1016\/j.lfs.2024.122954_bb0025","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1097\/j.pain.0000000000002525","article-title":"Prevalence and treatment of neuropathic pain diagnoses among U.S. nursing home residents","volume":"163","author":"Mbrah","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2024.122954_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116392","article-title":"Specific transcription factors Ascl1 and Lhx6 attenuate diabetic neuropathic pain by modulating spinal neuroinflammation and microglial activation in mice","volume":"173","author":"Hwang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2024.122954_bb0035","series-title":"GLP-1 and Its Derived Peptides Mediate Pain Relief Through Direct TRPV1 Inhibition Without Affecting Thermoregulation","first-page":"1","author":"H.S. Go","year":"2024"},{"issue":"1","key":"10.1016\/j.lfs.2024.122954_bb0040","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41573-021-00268-4","article-title":"Advances in TRP channel drug discovery: from target validation to clinical studies","volume":"21","author":"Koivisto","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2024.122954_bb0045","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5806321","article-title":"Multifunctional TRPV1 ion channels in physiology and pathology with focus on the brain, vasculature, and some visceral systems","volume":"2019","author":"Storozhuk","year":"2019","journal-title":"Biomed Res Int"},{"issue":"4","key":"10.1016\/j.lfs.2024.122954_bb0050","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.neuron.2012.02.039","article-title":"TRPV1 in GABAergic interneurons mediates neuropathic mechanical allodynia and disinhibition of the nociceptive circuitry in the spinal cord","volume":"74","author":"Kim","year":"2012","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.lfs.2024.122954_bb0055","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41594-021-00616-3","article-title":"Heat-dependent opening of TRPV1 in the presence of capsaicin","volume":"28","author":"Kwon","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"6653","key":"10.1016\/j.lfs.2024.122954_bb0060","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/39807","article-title":"The capsaicin receptor: a heat-activated ion channel in the pain pathway","volume":"389","author":"Caterina","year":"1997","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.lfs.2024.122954_bb0065","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0896-6273(00)80564-4","article-title":"The cloned capsaicin receptor integrates multiple pain-producing stimuli","volume":"21","author":"Tominaga","year":"1998","journal-title":"Neuron"},{"issue":"6783","key":"10.1016\/j.lfs.2024.122954_bb0070","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/35012076","article-title":"Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia","volume":"405","author":"Davis","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2024.122954_bb0075","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1146\/annurev.neuro.24.1.487","article-title":"The vanilloid receptor: a molecular gateway to the pain pathway","volume":"24","author":"Caterina","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.lfs.2024.122954_bb0080","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1021\/acs.jmedchem.9b01046","article-title":"Discovery of nonpungent transient receptor potential vanilloid 1 (TRPV1) agonist as strong topical analgesic","volume":"63","author":"Ann","year":"2020","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2024.122954_bb0085","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s40122-020-00161-9","article-title":"Efficacy and safety of diclofenac + capsaicin gel in patients with acute back\/neck pain: a multicenter randomized controlled study","volume":"9","author":"Predel","year":"2020","journal-title":"Pain Ther."},{"issue":"3","key":"10.1016\/j.lfs.2024.122954_bb0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/tvst.12.3.7","article-title":"Topical ocular TRPV1 antagonist SAF312 (Libvatrep) for postoperative pain after photorefractive keratectomy","volume":"12","author":"Thompson","year":"2023","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.lfs.2024.122954_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115806","article-title":"Progress in the development of TRPV1 small-molecule antagonists: novel strategies for pain management","volume":"261","author":"Zhu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2024.122954_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29010181","article-title":"Impact of TRPV1 on pathogenesis and therapy of neurodegenerative diseases","volume":"29","author":"Wang","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2024.122954_bb0105","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3389\/fphys.2019.01064","article-title":"The role of transient receptor potential vanilloid 1 in common diseases of the digestive tract and the cardiovascular and respiratory system","volume":"10","author":"Du","year":"2019","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122954_bb0110","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-22507-3","article-title":"Extracellular cap domain is an essential component of the TRPV1 gating mechanism","volume":"12","author":"Nadezhdin","year":"2021","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.lfs.2024.122954_bb0115","doi-asserted-by":"crossref","first-page":"8002","DOI":"10.1073\/pnas.1337252100","article-title":"Structural determinant of TRPV1 desensitization interacts with calmodulin","volume":"100","author":"Numazaki","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.lfs.2024.122954_bb0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1085\/jgp.200308906","article-title":"Ca2+\/calmodulin modulates TRPV1 activation by capsaicin","volume":"123","author":"Rosenbaum","year":"2004","journal-title":"J. Gen. Physiol."},{"issue":"6","key":"10.1016\/j.lfs.2024.122954_bb0125","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.neuron.2007.05.027","article-title":"The ankyrin repeats of TRPV1 bind multiple ligands and modulate channel sensitivity","volume":"54","author":"Lishko","year":"2007","journal-title":"Neuron"},{"issue":"7548","key":"10.1016\/j.lfs.2024.122954_bb0130","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nature14367","article-title":"Structure of the TRPA1 ion channel suggests regulatory mechanisms","volume":"520","author":"Paulsen","year":"2015","journal-title":"Nature"},{"issue":"37","key":"10.1016\/j.lfs.2024.122954_bb0135","doi-asserted-by":"crossref","first-page":"9385","DOI":"10.1523\/JNEUROSCI.1246-06.2006","article-title":"TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists","volume":"26","author":"Cui","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2024.122954_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.930964","article-title":"TRPV1 in chronic pruritus and pain: soft modulation as a therapeutic strategy","volume":"15","author":"Fernandez-Carvajal","year":"2022","journal-title":"Front. Mol. Neurosci."},{"issue":"3","key":"10.1016\/j.lfs.2024.122954_bb0145","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/pr.109.001263","article-title":"The transient receptor potential vanilloid-1 channel in thermoregulation: a thermosensor it is not","volume":"61","author":"Romanovsky","year":"2009","journal-title":"Pharmacol. Rev."},{"issue":"12","key":"10.1016\/j.lfs.2024.122954_bb0150","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1111\/bph.14044","article-title":"Targeting nociceptive transient receptor potential channels to treat chronic pain: current state of the field","volume":"175","author":"Moran","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.lfs.2024.122954_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120187","article-title":"Tiwari, unlocking the potential of TRPV1 based siRNA therapeutics for the treatment of chemotherapy-induced neuropathic pain","volume":"288","author":"Akhilesh","year":"2022","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.lfs.2024.122954_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21010342","article-title":"TRP channels in the focus of trigeminal nociceptor sensitization contributing to primary headaches","volume":"21","author":"Dux","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2024.122954_bb0165","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41392-023-01464-x","article-title":"TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.lfs.2024.122954_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/biom12010001","article-title":"TRP channels as molecular targets to relieve cancer pain","volume":"12","author":"Duitama","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.lfs.2024.122954_bb0175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1744-8069-6-85","article-title":"Involvement of lysophosphatidic acid in bone cancer pain by potentiation of TRPV1 via PKCepsilon pathway in dorsal root ganglion neurons","volume":"6","author":"Pan","year":"2010","journal-title":"Mol. Pain"},{"issue":"8","key":"10.1016\/j.lfs.2024.122954_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/biom13081193","article-title":"Nociceptor-macrophage interactions in apical periodontitis: how biomolecules link inflammation with pain","volume":"13","author":"Menon","year":"2023","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.lfs.2024.122954_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24055001","article-title":"Molecular mechanisms of neurogenic inflammation of the skin","volume":"24","author":"Marek-Jozefowicz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.122954_bb0190","doi-asserted-by":"crossref","DOI":"10.1177\/1744806920946889","article-title":"Endoplasmic reticulum-mitochondria interplay in chronic pain: the calcium connection","volume":"16","author":"Yousuf","year":"2020","journal-title":"Mol. Pain"},{"key":"10.1016\/j.lfs.2024.122954_bb0195","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.redox.2015.08.010","article-title":"Calcium and ROS: a mutual interplay","volume":"6","author":"Gorlach","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.lfs.2024.122954_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1232013","article-title":"The role of TRPV1 in RA pathogenesis: worthy of attention","volume":"14","author":"Qu","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.lfs.2024.122954_bb0205","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bbrc.2017.01.173","article-title":"Differences in the effects of four TRPV1 channel antagonists on lipopolysaccharide-induced cytokine production and COX-2 expression in murine macrophages","volume":"484","author":"Ninomiya","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.lfs.2024.122954_bb0210","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41419-021-03792-8","article-title":"TRPV1 alleviates osteoarthritis by inhibiting M1 macrophage polarization via Ca(2+)\/CaMKII\/Nrf2 signaling pathway","volume":"12","author":"Lv","year":"2021","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.lfs.2024.122954_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030821","article-title":"Reciprocal regulatory interaction between TRPV1 and kinin B1 receptor in a rat neuropathic pain model","volume":"21","author":"Cernit","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.122954_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109178","article-title":"Modulation of TRPV1 channel function by natural products in the treatment of pain","volume":"330","author":"Abbas","year":"2020","journal-title":"Chem. Biol. Interact."},{"issue":"6840","key":"10.1016\/j.lfs.2024.122954_bb0225","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/35082088","article-title":"Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition","volume":"411","author":"Chuang","year":"2001","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.lfs.2024.122954_bb0230","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1152\/jn.00356.2004","article-title":"A developmental switch in acute sensitization of small dorsal root ganglion (DRG) neurons to capsaicin or noxious heating by NGF","volume":"92","author":"Zhu","year":"2004","journal-title":"J. Neurophysiol."},{"issue":"3","key":"10.1016\/j.lfs.2024.122954_bb0235","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.neulet.2011.06.034","article-title":"Differential gene expression of neonatal and adult DRG neurons correlates with the differential sensitization of TRPV1 responses to nerve growth factor","volume":"500","author":"Zhu","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.lfs.2024.122954_bb0240","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12576-015-0397-0","article-title":"Delayed onset muscle soreness: involvement of neurotrophic factors","volume":"66","author":"Mizumura","year":"2016","journal-title":"J. Physiol. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2024.122954_bb0245","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1046\/j.1460-9568.1999.00503.x","article-title":"Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites","volume":"11","author":"Guo","year":"1999","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.lfs.2024.122954_bb0250","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neulet.2003.12.051","article-title":"The vanilloid receptor-1 is expressed in rat spinal dorsal horn astrocytes","volume":"357","author":"Doly","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.lfs.2024.122954_bb0255","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2003.10.001","article-title":"[3H]Resiniferatoxin autoradiography in the CNS of wild-type and TRPV1 null mice defines TRPV1 (VR-1) protein distribution","volume":"995","author":"Roberts","year":"2004","journal-title":"Brain Res."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2024.122954_bb0260","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0169-328X(01)00313-8","article-title":"Pharmacological characterization of vanilloid receptor located in the brain","volume":"98","author":"Szabo","year":"2002","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"7","key":"10.1016\/j.lfs.2024.122954_bb0265","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1073\/pnas.97.7.3655","article-title":"Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human","volume":"97","author":"Mezey","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.lfs.2024.122954_bb0270","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1523\/JNEUROSCI.6451-10.2011","article-title":"Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells","volume":"31","author":"Cavanaugh","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.lfs.2024.122954_bb0275","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1744-8069-6-66","article-title":"Moving towards supraspinal TRPV1 receptors for chronic pain relief","volume":"6","author":"Palazzo","year":"2010","journal-title":"Mol. Pain"},{"key":"10.1016\/j.lfs.2024.122954_bb0280","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15292","article-title":"TRPV1 channels are critical brain inflammation detectors and neuropathic pain biomarkers in mice","volume":"8","author":"Marrone","year":"2017","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.lfs.2024.122954_bb0285","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1046\/j.0953-816x.2001.01591.x","article-title":"VR1 protein expression increases in undamaged DRG neurons after partial nerve injury","volume":"13","author":"Hudson","year":"2001","journal-title":"Eur. J. Neurosci."},{"issue":"7","key":"10.1016\/j.lfs.2024.122954_bb0290","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.neuropharm.2005.05.003","article-title":"Involvement of an increased spinal TRPV1 sensitization through its up-regulation in mechanical allodynia of CCI rats","volume":"49","author":"Kanai","year":"2005","journal-title":"Neuropharmacology"},{"issue":"Pt 2","key":"10.1016\/j.lfs.2024.122954_bb0295","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1113\/jphysiol.2006.118620","article-title":"Potentiation of glutamatergic synaptic transmission by protein kinase C-mediated sensitization of TRPV1 at the first sensory synapse","volume":"581","author":"Sikand","year":"2007","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122954_bb0300","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1152\/jn.2002.88.1.544","article-title":"Bradykinin lowers the threshold temperature for heat activation of vanilloid receptor 1","volume":"88","author":"Sugiura","year":"2002","journal-title":"J. Neurophysiol."},{"issue":"4","key":"10.1016\/j.lfs.2024.122954_bb0305","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.bbrc.2007.05.178","article-title":"Expression of transient receptor potential vanilloid 1 (TRPV1) in synovial fibroblasts from patients with osteoarthritis and rheumatoid arthritis","volume":"359","author":"Engler","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.lfs.2024.122954_bb0310","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neulet.2005.06.044","article-title":"Regulation of calcitonin gene-related peptide and TRPV1 in a rat model of osteoarthritis","volume":"388","author":"Fernihough","year":"2005","journal-title":"Neurosci. Lett."},{"issue":"11","key":"10.1016\/j.lfs.2024.122954_bb0315","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.joca.2010.09.005","article-title":"Paradoxical effects of the cannabinoid CB2 receptor agonist GW405833 on rat osteoarthritic knee joint pain","volume":"18","author":"Schuelert","year":"2010","journal-title":"Osteoarthr. Cartil."},{"issue":"8","key":"10.1016\/j.lfs.2024.122954_bb0320","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ejca.2008.03.001","article-title":"Challenges in cancer pain management\u2014bone pain","volume":"44","author":"Colvin","year":"2008","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2024.122954_bb0325","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/bja\/aen100","article-title":"Translational medicine: cancer pain mechanisms and management","volume":"101","author":"Delaney","year":"2008","journal-title":"Br. J. Anaesth."},{"issue":"33","key":"10.1016\/j.lfs.2024.122954_bb0330","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1200\/JCO.2010.28.6559","article-title":"Neuropathic pain features in patients with bone metastases referred for palliative radiotherapy","volume":"28","author":"Kerba","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.lfs.2024.122954_bb0335","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1523\/JNEUROSCI.3815-04.2005","article-title":"Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain","volume":"25","author":"Ghilardi","year":"2005","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.lfs.2024.122954_bb0340","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.neuroscience.2007.05.049","article-title":"Bone cancer increases transient receptor potential vanilloid subfamily 1 expression within distinct subpopulations of dorsal root ganglion neurons","volume":"148","author":"Niiyama","year":"2007","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.lfs.2024.122954_bb0345","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s40265-020-01429-2","article-title":"TRPV1-targeted drugs in development for human pain conditions","volume":"81","author":"Iftinca","year":"2021","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.lfs.2024.122954_bb0350","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/138920111793937826","article-title":"A \u201ccute\u201d desensitization of TRPV1","volume":"12","author":"Touska","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"2\u20133","key":"10.1016\/j.lfs.2024.122954_bb0355","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejphar.2010.05.022","article-title":"Pre-treatment with capsaicin in a rat osteoarthritis model reduces the symptoms of pain and bone damage induced by monosodium iodoacetate","volume":"641","author":"Kalff","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.lfs.2024.122954_bb0360","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2147\/JPR.S395065","article-title":"The preemptive analgesic effect of capsaicin involves attenuations of epidermal keratinocytes proliferation and expression of pro-inflammatory mediators after plantar incision in rats","volume":"16","author":"Guo","year":"2023","journal-title":"J. Pain Res."},{"issue":"8","key":"10.1016\/j.lfs.2024.122954_bb0365","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1097\/j.pain.0000000000002529","article-title":"Capsaicin-induced depolymerization of axonal microtubules mediates analgesia for trigeminal neuropathic pain","volume":"163","author":"Arora","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2024.122954_bb0370","first-page":"547","article-title":"Effect of delayed intrathecal administration of capsaicin on neuropathic pain induced by chronic constriction injury of the sciatic nerve in rats","volume":"7","author":"Zhang","year":"2014","journal-title":"J. Pain Res."},{"issue":"1","key":"10.1016\/j.lfs.2024.122954_bb0375","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4196\/kjpp.2016.20.1.129","article-title":"The effects of intra-articular resiniferatoxin on monosodium iodoacetate-induced osteoarthritic pain in rats","volume":"20","author":"Kim","year":"2016","journal-title":"Korean J Physiol Pharmacol"},{"issue":"12","key":"10.1016\/j.lfs.2024.122954_bb0380","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1093\/pm\/pnw260","article-title":"Local resiniferatoxin induces long-lasting analgesia in a rat model of full thickness thermal injury","volume":"18","author":"Salas","year":"2017","journal-title":"Pain Med."},{"issue":"Pt 3","key":"10.1016\/j.lfs.2024.122954_bb0385","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1113\/jphysiol.2005.087874","article-title":"Activation of transient receptor potential vanilloid 1 (TRPV1) by resiniferatoxin","volume":"567","author":"Raisinghani","year":"2005","journal-title":"J. Physiol."},{"issue":"5","key":"10.1016\/j.lfs.2024.122954_bb0390","first-page":"259","article-title":"NE-19550: a novel, orally active anti-inflammatory analgesic","volume":"13","author":"Brand","year":"1987","journal-title":"Drugs Exp. Clin. Res."},{"issue":"2","key":"10.1016\/j.lfs.2024.122954_bb0395","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.bjp.0703050","article-title":"The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)","volume":"129","author":"Smart","year":"2000","journal-title":"Br. J. Pharmacol."},{"issue":"16","key":"10.1016\/j.lfs.2024.122954_bb0400","doi-asserted-by":"crossref","first-page":"13633","DOI":"10.1074\/jbc.M211231200","article-title":"N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia","volume":"278","author":"Chu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2024.122954_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107743","article-title":"Fight fire with fire: neurobiology of capsaicin-induced analgesia for chronic pain","volume":"220","author":"Arora","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"Pt 1","key":"10.1016\/j.lfs.2024.122954_bb0410","article-title":"Research progress and challenges of TRPV1 channel modulators as a prospective therapy for diabetic neuropathic pain","volume":"245","author":"Liu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"20","key":"10.1016\/j.lfs.2024.122954_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/nu15204469","article-title":"Are we ready to recommend capsaicin for disorders other than neuropathic pain?","volume":"15","author":"Silva","year":"2023","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.lfs.2024.122954_bb0420","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.pain.2013.02.023","article-title":"Effect of paclitaxel on transient receptor potential vanilloid 1 in rat dorsal root ganglion","volume":"154","author":"Hara","year":"2013","journal-title":"Pain"},{"issue":"23","key":"10.1016\/j.lfs.2024.122954_bb0425","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20235917","article-title":"Electroacupuncture alleviates paclitaxel-induced peripheral neuropathic pain in rats via suppressing TLR4 signaling and TRPV1 upregulation in sensory neurons","volume":"20","author":"Li","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.lfs.2024.122954_bb0430","article-title":"Antinociceptive effect of Dendrobii caulis in paclitaxel-induced neuropathic pain in mice","volume":"13","author":"Park","year":"2023","journal-title":"Life (Basel)"},{"issue":"12","key":"10.1016\/j.lfs.2024.122954_bb0435","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124341","article-title":"Paclitaxel induces upregulation of transient receptor potential vanilloid 1 expression in the rat spinal cord","volume":"21","author":"Kamata","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.lfs.2024.122954_bb0440","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.2174\/156802611796904898","article-title":"Therapeutic targeting of TRP channels\u2014the TR(i)P to pain relief","volume":"11","author":"Eid","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2024.122954_bb0445","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0304-3940(91)90496-G","article-title":"Capsazepine, a novel capsaicin antagonist, selectively antagonises the effects of capsaicin in the mouse spinal cord in vitro","volume":"134","author":"Urban","year":"1991","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.lfs.2024.122954_bb0450","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1124\/jpet.102.045674","article-title":"N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. In vitro characterization and pharmacokinetic properties","volume":"306","author":"Valenzano","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"15","key":"10.1016\/j.lfs.2024.122954_bb0455","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1021\/jm070189q","article-title":"Novel vanilloid receptor-1 antagonists: 1. Conformationally restricted analogues of trans-cinnamides","volume":"50","author":"Norman","year":"2007","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.lfs.2024.122954_bb0460","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1021\/jm7014638","article-title":"Design and synthesis of peripherally restricted transient receptor potential vanilloid 1 (TRPV1) antagonists","volume":"51","author":"Tamayo","year":"2008","journal-title":"J. Med. Chem."},{"issue":"15","key":"10.1016\/j.lfs.2024.122954_bb0465","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1021\/jm070191h","article-title":"Novel vanilloid receptor-1 antagonists: 3. The identification of a second-generation clinical candidate with improved physicochemical and pharmacokinetic properties","volume":"50","author":"Wang","year":"2007","journal-title":"J Med Chem"},{"issue":"11","key":"10.1016\/j.lfs.2024.122954_bb0470","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1016\/j.bmcl.2012.04.034","article-title":"Structure-activity relationships and molecular modeling of the N-(3-pivaloyloxy-2-benzylpropyl)-N\u2032-[4-(methylsulfonylamino)benzyl] thiourea template for TRPV1 antagonism","volume":"22","author":"Bhondwe","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"7","key":"10.1016\/j.lfs.2024.122954_bb0475","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1021\/jm300101n","article-title":"Discovery of novel 5,5-diarylpentadienamides as orally available transient receptor potential vanilloid 1 (TRPV1) antagonists","volume":"55","author":"Saku","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2024.122954_bb0480","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.80139","article-title":"TRPV1 drugs alter core body temperature via central projections of primary afferent sensory neurons","volume":"11","author":"Yue","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.lfs.2024.122954_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107474","article-title":"Hyperthermia induced by transient receptor potential vanilloid-1 (TRPV1) antagonists in human clinical trials: insights from mathematical modeling and meta-analysis","volume":"208","author":"Garami","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.lfs.2024.122954_bb0490","doi-asserted-by":"crossref","first-page":"42","DOI":"10.32607\/actanaturae.11829","article-title":"Analysis of the involvement of NMDA receptors in analgesia and hypothermia induced by the activation of TRPV1 ion channels","volume":"15","author":"Ivanova","year":"2023","journal-title":"Acta Nat."},{"issue":"1","key":"10.1016\/j.lfs.2024.122954_bb0495","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1038\/s41598-019-39184-4","article-title":"Silencing of spinal Trpv1 attenuates neuropathic pain in rats by inhibiting CAMKII expression and ERK2 phosphorylation","volume":"9","author":"Guo","year":"2019","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.lfs.2024.122954_bb0500","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1080\/01616412.2019.1639317","article-title":"AAV-mediated siRNA against TRPV1 reduces nociception in a rat model of bone cancer pain","volume":"41","author":"Zhang","year":"2019","journal-title":"Neurol. Res."},{"issue":"5","key":"10.1016\/j.lfs.2024.122954_bb0505","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/0964528420968845","article-title":"Effects of low- and high-frequency electroacupuncture on protein expression and distribution of TRPV1 and P2X3 in rats with peripheral nerve injury","volume":"39","author":"Du","year":"2021","journal-title":"Acupunct. Med."},{"issue":"2","key":"10.1016\/j.lfs.2024.122954_bb0510","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/mt.2013.247","article-title":"Intrathecal AAV serotype 9-mediated delivery of shRNA against TRPV1 attenuates thermal hyperalgesia in a mouse model of peripheral nerve injury","volume":"22","author":"Hirai","year":"2014","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.lfs.2024.122954_bb0515","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1111\/j.1460-9568.2007.05584.x","article-title":"RNA interference-mediated knock-down of transient receptor potential vanilloid 1 prevents forepaw inflammatory hyperalgesia in rat","volume":"25","author":"Kasama","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.lfs.2024.122954_bb0520","article-title":"siRNA specificity: RNAi mechanisms and strategies to reduce off-target effects","volume":"11","author":"Neumeier","year":"2020","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.lfs.2024.122954_bb0525","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.omtn.2020.07.012","article-title":"Introducing an in vitro liver stability assay capable of predicting the in vivo pharmacodynamic efficacy of siRNAs for IVIVC","volume":"21","author":"Basiri","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"issue":"6","key":"10.1016\/j.lfs.2024.122954_bb0530","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jpain.2017.01.009","article-title":"Safety, pharmacokinetics, and pharmacodynamics study in healthy subjects of oral NEO6860, a modality selective transient receptor potential vanilloid subtype 1 antagonist","volume":"18","author":"Brown","year":"2017","journal-title":"J. Pain"},{"issue":"9","key":"10.1016\/j.lfs.2024.122954_bb0535","article-title":"Clinical results of tivanisiran, a siRNA for the treatment of dry eye disease","volume":"60","author":"Ruz","year":"2019","journal-title":"Invest Ophth Vis Sci"},{"issue":"9","key":"10.1016\/j.lfs.2024.122954_bb0540","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/art.40894","article-title":"Randomized, double-blind, placebo-controlled trial of intraarticular trans-capsaicin for pain associated with osteoarthritis of the knee","volume":"71","author":"Stevens","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.lfs.2024.122954_bb0555","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jocn.2018.11.036","article-title":"0.075% capsaicin lotion for the treatment of painful diabetic neuropathy: a randomized, double-blind, crossover, placebo-controlled trial","volume":"62","author":"Kulkantrakorn","year":"2019","journal-title":"J. Clin. Neurosci."},{"issue":"10","key":"10.1016\/j.lfs.2024.122954_bb0565","first-page":"656","article-title":"Herpes zoster and postherpetic neuralgia: prevention and management","volume":"96","author":"Saguil","year":"2017","journal-title":"Am. Fam. Physician"},{"issue":"1","key":"10.1016\/j.lfs.2024.122954_bb0580","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/23328940.2023.2171671","article-title":"The neural pathway of the hyperthermic response to antagonists of the transient receptor potential vanilloid-1 channel","volume":"10","author":"Garami","year":"2023","journal-title":"Temperature (Austin)"},{"key":"10.1016\/j.lfs.2024.122954_bb0585","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/B978-0-12-396493-9.00002-9","article-title":"TRPV1 antagonists: clinical setbacks and prospects for future development","volume":"51","author":"Kort","year":"2012","journal-title":"Prog. Med. Chem."},{"issue":"10","key":"10.1016\/j.lfs.2024.122954_bb0590","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/ejp.1451","article-title":"The effect of intradermal microdosing of a transient receptor potential cation channel subfamily V member 1 antagonist on heat evoked pain and thermal thresholds in normal and ultraviolet-C exposed skin in healthy volunteers","volume":"23","author":"Sjogren","year":"2019","journal-title":"Eur. J. Pain"},{"issue":"6","key":"10.1016\/j.lfs.2024.122954_bb0595","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.pain.2013.02.004","article-title":"TRPV1 antagonistic analgesic effect: a randomized study of AZD1386 in pain after third molar extraction","volume":"154","author":"Quiding","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2024.122954_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdermsci.2018.04.017","article-title":"A novel, topical, nonsteroidal, TRPV1 antagonist, PAC-14028 cream improves skin barrier function and exerts anti-inflammatory action through modulating epidermal differentiation markers and suppressing Th2 cytokines in atopic dermatitis","author":"Lee","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.lfs.2024.122954_bb0610","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.sjpain.2017.07.021","article-title":"A randomized study to evaluate the analgesic efficacy of a single dose of the TRPV1 antagonist mavatrep in patients with osteoarthritis","volume":"17","author":"Mayorga","year":"2017","journal-title":"Scand. J. Pain"},{"issue":"2","key":"10.1016\/j.lfs.2024.122954_bb0615","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1515\/sjpain-2017-0184","article-title":"A multiple-dose double-blind randomized study to evaluate the safety, pharmacokinetics, pharmacodynamics and analgesic efficacy of the TRPV1 antagonist JNJ-39439335 (mavatrep)","volume":"18","author":"Manitpisitkul","year":"2018","journal-title":"Scand J Pain"},{"issue":"6","key":"10.1016\/j.lfs.2024.122954_bb0620","article-title":"NEO6860, modality-selective TRPV1 antagonist: a randomized, controlled, proof-of-concept trial in patients with osteoarthritis knee pain","volume":"3","author":"Arsenault","year":"2018","journal-title":"Pain Rep"},{"issue":"9","key":"10.1016\/j.lfs.2024.122954_bb0625","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1097\/j.pain.0000000000000610","article-title":"A randomized, double-blind, positive-controlled, 3-way cross-over human experimental pain study of a TRPV1 antagonist (V116517) in healthy volunteers and comparison with preclinical profile","volume":"157","author":"Arendt-Nielsen","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.lfs.2024.122954_bb0635","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejmech.2019.06.007","article-title":"Design, synthesis and biological evaluation of novel 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole triazole derivatives as potent TRPV1 antagonists","volume":"178","author":"Li","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2024.122954_bb0640","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1021\/acs.jmedchem.0c00982","article-title":"Discovery of benzopyridone-based transient receptor potential vanilloid 1 agonists and antagonists and the structural elucidation of their activity shift","volume":"64","author":"Thorat","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2024.122954_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128266","article-title":"2-(Halogenated phenyl) acetamides and propanamides as potent TRPV1 antagonists","volume":"48","author":"Kang","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.lfs.2024.122954_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113042","article-title":"Paracetamol analogues conjugated by FAAH induce TRPV1-mediated antinociception without causing acute liver toxicity","volume":"213","author":"Nilsson","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.lfs.2024.122954_bb0655","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/cbdd.14270","article-title":"Discovery of novel TRPV1 modulators through machine learning-based molecular docking and molecular similarity searching","volume":"102","author":"Wei","year":"2023","journal-title":"Chem. Biol. Drug Des."},{"issue":"1","key":"10.1016\/j.lfs.2024.122954_bb0660","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1080\/14756366.2022.2110089","article-title":"A new era for the design of TRPV1 antagonists and agonists with the use of structural information and molecular docking of capsaicin-like compounds","volume":"37","author":"Caballero","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"7607","key":"10.1016\/j.lfs.2024.122954_bb0665","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature17964","article-title":"TRPV1 structures in nanodiscs reveal mechanisms of ligand and lipid action","volume":"534","author":"Gao","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.lfs.2024.122954_bb0670","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163735","article-title":"A human TRPV1 genetic variant within the channel gating domain regulates pain sensitivity in rodents","volume":"133","author":"He","year":"2023","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.lfs.2024.122954_bb0675","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.3390\/app13095617","article-title":"Drug\u2013target interaction deep learning-based model identifies the flavonoid troxerutin as a candidate TRPV1 antagonist","volume":"13","author":"Jinyong Lee","year":"2023","journal-title":"Appl. Sci."},{"issue":"40","key":"10.1016\/j.lfs.2024.122954_bb0680","doi-asserted-by":"crossref","first-page":"11342","DOI":"10.1073\/pnas.1604269113","article-title":"Low-cost functional plasticity of TRPV1 supports heat tolerance in squirrels and camels","volume":"113","author":"Laursen","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.lfs.2024.122954_bb0685","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119123","article-title":"Genetic diversity of a heat activated channel-TRPV1 in two desert gerbil species with different heat sensitivity","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2024.122954_bb0690","doi-asserted-by":"crossref","DOI":"10.1093\/gbe\/evac009","article-title":"Evolution of transient receptor potential (TRP) ion channels in Antarctic fishes (Cryonotothenioidea) and identification of putative thermosensors","volume":"14","author":"York","year":"2022","journal-title":"Genome Biol. Evol."},{"issue":"1","key":"10.1016\/j.lfs.2024.122954_bb0695","doi-asserted-by":"crossref","first-page":"52","DOI":"10.24272\/j.issn.2095-8137.2021.209","article-title":"Unexpected expression of heat-activated transient receptor potential (TRP) channels in winter torpid bats and cold-activated TRP channels in summer active bats","volume":"43","author":"Li","year":"2022","journal-title":"Zool. Res."},{"issue":"5","key":"10.1016\/j.lfs.2024.122954_bb0700","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/carcin\/bgr037","article-title":"TRPV1-antagonist AMG9810 promotes mouse skin tumorigenesis through EGFR\/Akt signaling","volume":"32","author":"Li","year":"2011","journal-title":"Carcinogenesis"},{"issue":"24","key":"10.1016\/j.lfs.2024.122954_bb0705","doi-asserted-by":"crossref","first-page":"16675","DOI":"10.1074\/jbc.M114.558668","article-title":"Targeting the transient receptor potential vanilloid type 1 (TRPV1) assembly domain attenuates inflammation-induced hypersensitivity","volume":"289","author":"Flynn","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"Pt 5","key":"10.1016\/j.lfs.2024.122954_bb0710","article-title":"Novel marine natural products as effective TRPV1 channel blockers","volume":"253","author":"Ye","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"6","key":"10.1016\/j.lfs.2024.122954_bb0715","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2174\/1389201022666210719155931","article-title":"Natural products and some semi-synthetic analogues as potential TRPV1 ligands for attenuating neuropathic pain","volume":"23","author":"Naik","year":"2022","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"15","key":"10.1016\/j.lfs.2024.122954_bb0720","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1021\/jm070190p","article-title":"Novel vanilloid receptor-1 antagonists: 2. Structure-activity relationships of 4-oxopyrimidines leading to the selection of a clinical candidate","volume":"50","author":"Doherty","year":"2007","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.lfs.2024.122954_bb0725","doi-asserted-by":"crossref","first-page":"9855","DOI":"10.1021\/acs.jmedchem.6b01191","article-title":"Radiofluorinated N-octanoyl dopamine ([(18)F]F-NOD) as a tool to study tissue distribution and elimination of NOD in vitro and in vivo","volume":"59","author":"Pretze","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.lfs.2024.122954_bb0730","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.biocel.2019.04.010","article-title":"Chalcone derivatives as non-canonical ligands of TRPV1","volume":"112","author":"Benso","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"21","key":"10.1016\/j.lfs.2024.122954_bb0735","doi-asserted-by":"crossref","first-page":"6657","DOI":"10.1016\/j.bmc.2013.08.015","article-title":"TRPV1 antagonist with high analgesic efficacy: 2-thio pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides","volume":"21","author":"Ha","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2024.122954_bb0740","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/26895293.2020.1861111","article-title":"TRPV1 is involved in the antinociceptive effects of resveratrol in paclitaxel-induced neuropathic pain","volume":"14","author":"Yaodong Zhang","year":"2021","journal-title":"All Life"},{"issue":"9","key":"10.1016\/j.lfs.2024.122954_bb0745","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/aps.2016.58","article-title":"Quercetin ameliorates paclitaxel-induced neuropathic pain by stabilizing mast cells, and subsequently blocking PKCepsilon-dependent activation of TRPV1","volume":"37","author":"Gao","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.lfs.2024.122954_bb0750","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s13760-018-1006-9","article-title":"The antiviral alkaloid berberine ameliorates neuropathic pain in rats with peripheral nerve injury","volume":"120","author":"Yang","year":"2020","journal-title":"Acta Neurol. Belg."},{"issue":"3","key":"10.1016\/j.lfs.2024.122954_bb0755","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030547","article-title":"Decursin alleviates mechanical allodynia in a paclitaxel-induced neuropathic pain mouse model","volume":"10","author":"Son","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2024.122954_bb0760","doi-asserted-by":"crossref","DOI":"10.1177\/1744806917726416","article-title":"Oral administration of curcumin attenuates visceral hyperalgesia through inhibiting phosphorylation of TRPV1 in rat model of ulcerative colitis","volume":"13","author":"Yang","year":"2017","journal-title":"Mol. Pain"},{"issue":"16","key":"10.1016\/j.lfs.2024.122954_bb0765","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168811","article-title":"JI017 attenuates oxaliplatin-induced cold allodynia via spinal TRPV1 and astrocytes inhibition in mice","volume":"22","author":"Lee","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.lfs.2024.122954_bb0770","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22116084","article-title":"Suppression of TRPV1\/TRPM8\/P2Y nociceptors by withametelin via downregulating MAPK signaling in mouse model of vincristine-induced neuropathic pain","volume":"22","author":"Khan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.lfs.2024.122954_bb0775","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105772","article-title":"Venom peptide toxins targeting the outer pore region of transient receptor potential vanilloid 1 in pain: implications for analgesic drug development","volume":"23","author":"Hwang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2024.122954_bb0780","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bbagen.2017.01.004","article-title":"Protein toxins of the Echis coloratus viper venom directly activate TRPV1","volume":"1861","author":"Geron","year":"2017","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"9","key":"10.1016\/j.lfs.2024.122954_bb0785","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.3390\/toxins7093671","article-title":"Scorpion toxin, BmP01, induces pain by targeting TRPV1 channel","volume":"7","author":"Hakim","year":"2015","journal-title":"Toxins (Basel)"},{"issue":"5","key":"10.1016\/j.lfs.2024.122954_bb0790","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.cell.2010.03.052","article-title":"A bivalent tarantula toxin activates the capsaicin receptor, TRPV1, by targeting the outer pore domain","volume":"141","author":"Bohlen","year":"2010","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.lfs.2024.122954_bb0795","doi-asserted-by":"crossref","first-page":"5100","DOI":"10.3390\/md11125100","article-title":"Polypeptide modulators of TRPV1 produce analgesia without hyperthermia","volume":"11","author":"Andreev","year":"2013","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.lfs.2024.122954_bb0800","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.toxicon.2013.05.016","article-title":"Different types of toxins targeting TRPV1 in pain","volume":"71","author":"Min","year":"2013","journal-title":"Toxicon"},{"issue":"47","key":"10.1016\/j.lfs.2024.122954_bb0805","doi-asserted-by":"crossref","first-page":"15544","DOI":"10.1021\/bi051494l","article-title":"An inhibitor of TRPV1 channels isolated from funnel web spider venom","volume":"44","author":"Kitaguchi","year":"2005","journal-title":"Biochemistry"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524005447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524005447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T23:02:29Z","timestamp":1778713349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524005447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":154,"alternative-id":["S0024320524005447"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122954","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current insights and therapeutic strategies for targeting TRPV1 in neuropathic pain management","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122954","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"122954"}}